Experimental group 3:Baofukang suppository, high dose

2 trials

Sponsors

Beijing Tsinghua Changgeng Hospital

Conditions

HR-HPV16 / 18 infection with P16 positive CIN ?

Phase 2

Efficacy and safety of Baofukang suppository in the treatment of HR-HPV16 / 18 infection with P16 positive CIN II: a randomized, double-blind, placebo-controlled, multicenter phase II clinical trial

Active, not recruitingChiCTR2100043958

Beijing Tsinghua Changgeng HospitalHR-HPV16 / 18 infection with P16 positive CIN ?

Start: 2021-03-09Updated: 2021-07-12

Efficacy and safety of Baofukang suppository in the treatment of HR-HPV16 / 18 infection with P16 positive CIN II: a randomized, double-blind, placebo-controlled, multicenter phase II clinical trial

Active, not recruitingITMCTR2100004529

Beijing Tsinghua Changgeng HospitalHR-HPV16 / 18 infection with P16 positive CIN ?

Start: 2021-03-09Updated: 2023-02-20